Bill

Bill > A5948


NJ A5948

NJ A5948
Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.


summary

Introduced
11/18/2019
In Committee
11/18/2019
Crossed Over
Passed
Dead
01/08/2020

Introduced Session

2018-2019 Regular Session

Bill Summary

This bill requires that carriers that provide coverage for prescription drugs pursuant to the terms of a health benefits plan offered by the carrier are prohibited from requiring a covered person to pay an amount exceeding $100 for a 30 day supply of insulin; or an amount exceeding $100 for a package of two epinephrine auto-injector devices. In addition, the bill requires the Division of Consumer Affairs in the Department of Law and Public Safety to investigate the pricing of prescription insulin drugs that are available to New Jersey consumers to determine whether additional consumer protections in the pricing of prescription insulin drugs are needed. The division is required to issue and make available to the public a report detailing its findings and present the report to the Governor, the Commissioner of Banking and Insurance, and the Legislature.

AI Summary

This bill requires that carriers providing health insurance coverage in New Jersey cannot charge covered individuals more than $100 for a 30-day supply of insulin or a package of two epinephrine auto-injector devices. Additionally, the bill directs the Division of Consumer Affairs to investigate the pricing of prescription insulin drugs in the state and issue a report with recommendations on how to control and prevent the overpricing of these drugs and prevent deceptive sales practices related to their sale.

Committee Categories

Business and Industry

Sponsors (2)

Last Action

Introduced, Referred to Assembly Financial Institutions and Insurance Committee (on 11/18/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...